Emergent Biosolutions (EBS) had the highest return in 2008 by a small-cap US stock, returning 421.2%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Emergent Biosolutions (EBS) | 2008 | 421.16% |
Crawford (CRD.B) | 2008 | 251.21% |
Sanara Medtech (SMTI) | 2008 | 231.68% |
Axogen (AXGN) | 2008 | 111.54% |
Crawford (CRD.A) | 2008 | 87.74% |
Republic Bancorp (RBCAA) | 2008 | 69.56% |
Sapiens International (SPNS) | 2008 | 60.01% |
Vaalco Energy (EGY) | 2008 | 60% |
National Presto Industries (NPK) | 2008 | 58.16% |
Univest Corporation Pennsylvania (UVSP) | 2008 | 57.28% |
Capitol Federal Financial (CFFN) | 2008 | 54.8% |
Tompkins Financial (TMP) | 2008 | 53.7% |
Allegiant Travel (ALGT) | 2008 | 51.45% |
First Financial Corporation Indiana (THFF) | 2008 | 48.01% |
Stepan (SCL) | 2008 | 47.48% |
Compass Minerals International (CMP) | 2008 | 46.25% |
Myriad Genetics (MYGN) | 2008 | 44.04% |
MiMedx (MDXG) | 2008 | 42.33% |
1st Source (SRCE) | 2008 | 41.59% |
Ituran Location and Control (ITRN) | 2008 | 40.75% |
Community Trust Bancorp (CTBI) | 2008 | 38.53% |
Marten Transport (MRTN) | 2008 | 36.4% |
Burke & Herbert Financial Services Corp Common Stock (BHRB) | 2008 | 36.27% |
EZCORP (EZPW) | 2008 | 35.08% |
Celldex Therapeutics (CLDX) | 2008 | 34.69% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
